DK146785D0 - Pharmaceutisk praeparat med indhold af 9alfa, 11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion - Google Patents

Pharmaceutisk praeparat med indhold af 9alfa, 11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion

Info

Publication number
DK146785D0
DK146785D0 DK146785A DK146785A DK146785D0 DK 146785 D0 DK146785 D0 DK 146785D0 DK 146785 A DK146785 A DK 146785A DK 146785 A DK146785 A DK 146785A DK 146785 D0 DK146785 D0 DK 146785D0
Authority
DK
Denmark
Prior art keywords
methyl
oxycarbonyldicyclohexylmethyloxypregna
9alfa
16alfa
11beta
Prior art date
Application number
DK146785A
Other languages
English (en)
Other versions
DK146785A (da
DK164478B (da
DK164478C (da
Inventor
Francoise Delevallee
Roger Deraedt
Simone Jouquey
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of DK146785D0 publication Critical patent/DK146785D0/da
Publication of DK146785A publication Critical patent/DK146785A/da
Publication of DK164478B publication Critical patent/DK164478B/da
Application granted granted Critical
Publication of DK164478C publication Critical patent/DK164478C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK146785A 1984-04-03 1985-04-01 Anvendelse af 9alpha,11beta-dichlor-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion til fremstilling af et farmaceutisk praeparat til behandling af betaendelsestilstande i retcum eller colon DK164478C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8405222A FR2561919B1 (fr) 1984-04-03 1984-04-03 Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon
FR8405222 1984-04-03

Publications (4)

Publication Number Publication Date
DK146785D0 true DK146785D0 (da) 1985-04-01
DK146785A DK146785A (da) 1985-10-04
DK164478B DK164478B (da) 1992-07-06
DK164478C DK164478C (da) 1992-11-23

Family

ID=9302777

Family Applications (1)

Application Number Title Priority Date Filing Date
DK146785A DK164478C (da) 1984-04-03 1985-04-01 Anvendelse af 9alpha,11beta-dichlor-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion til fremstilling af et farmaceutisk praeparat til behandling af betaendelsestilstande i retcum eller colon

Country Status (16)

Country Link
US (1) US4614736A (da)
EP (1) EP0161144B1 (da)
JP (1) JPS60224615A (da)
AT (1) ATE41604T1 (da)
AU (1) AU571073B2 (da)
CA (1) CA1226817A (da)
DE (1) DE3568944D1 (da)
DK (1) DK164478C (da)
FR (1) FR2561919B1 (da)
GR (1) GR850815B (da)
HU (1) HU196122B (da)
IL (1) IL74642A (da)
MA (1) MA20388A1 (da)
OA (1) OA07978A (da)
PT (1) PT80214B (da)
ZA (1) ZA851927B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
US5578576A (en) * 1994-09-02 1996-11-26 Dalhousie University Method and composition for treating intestinal wounds or ulcers
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462443A1 (fr) * 1979-07-26 1981-02-13 Roussel Uclaf Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
FR2533928A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
PT80214A (en) 1985-05-01
AU571073B2 (en) 1988-03-31
IL74642A0 (en) 1985-06-30
DK146785A (da) 1985-10-04
EP0161144B1 (fr) 1989-03-22
DK164478B (da) 1992-07-06
OA07978A (fr) 1987-01-31
US4614736A (en) 1986-09-30
IL74642A (en) 1988-09-30
HUT44436A (en) 1988-03-28
MA20388A1 (fr) 1985-10-01
DK164478C (da) 1992-11-23
GR850815B (da) 1985-07-23
PT80214B (en) 1987-02-17
ATE41604T1 (de) 1989-04-15
DE3568944D1 (en) 1989-04-27
CA1226817A (fr) 1987-09-15
FR2561919B1 (fr) 1986-12-19
FR2561919A1 (fr) 1985-10-04
EP0161144A1 (fr) 1985-11-13
HU196122B (en) 1988-10-28
JPS60224615A (ja) 1985-11-09
ZA851927B (en) 1986-04-30
AU4080085A (en) 1985-10-10

Similar Documents

Publication Publication Date Title
IT1186181B (it) Composizioni analgesiche e antiinfiammatorie comprendenti difeni dramina e metodo di usare le stesse
DE3585981D1 (de) Behandlung gewebedegenerativer entzuendungskrankheiten.
MX9203403A (es) Carboxilatos heterociclicos 17-aromaticos de 3,20-dioxo-1,4-pregnadieno 17&-ol.
EP0493362A3 (en) Compositions and kits for the treatment of oral diseases
LU88750I2 (fr) VENLAFAXINE et ses dérivés pharmaceutiquement acceptables
ATE31243T1 (de) Verwendung von 4-aminosalicylsaeure als entzuendungshemmender wirkstoff.
DE3485647D1 (de) Steroide und diese enthaltende therapeutische zusammensetzungen.
ES514633A0 (es) "metodo de preparar compuestos esteroidicos antiinflamatorios".
EP0069232A3 (en) Purified antineoplaston fractions and methods of treating neoplastic disease
FI842457A0 (fi) 1-alkyl-androsta-1,4-dien-3,17-dioner, deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska produkter.
FI830523A0 (fi) Anti-inflammatoriska och/eller smaerta lindrande 2,3-diaryl-5-halotiofener
DK146785A (da) Pharmaceutisk praeparat med indhold af 9alfa, 11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion
IT7824578A0 (it) Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza.
RO79426A2 (ro) Compozitie medicamentoasa pentru tratamentul unor neuroviroze
DK92183D0 (da) 11beta-chlor-delta15-steroider, fremgangsmade til fremstilling heraf og farmaceutiske praeparater med indhold heraf
SE8503064L (sv) Behandling av radioaktivt avfall
FI831258L (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara benzimidazolderivat
FR2496466B1 (fr) Production d'hormone lactogene, placentaire, humaine
SE8304850D0 (sv) Behandling av brensletorv
IT1197029B (it) Antiinfiammatori non steroidei
ATE18136T1 (de) Allelspezifisches immunotherapeutisches verfahren und verabreichungsform.
IT7926204A0 (it) Glucosammide dell'acido p-isobutilfenilpropionico ad azione terapeutica e procedimento per lasua preparazione.
ATE75617T1 (de) Behandlung gewebedegenerativer entzuendungskrankheiten.
ZA824178B (en) Purified antineoplaston fractions and methods of treating neoplastic disease
RO87034A2 (ro) Medicament pentru tratamentul afectiunilor reumatismale

Legal Events

Date Code Title Description
PBP Patent lapsed